Cargando…

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma

Methylation of the Ras-association domain family 10 (RASSF10) promoter region correlates with clinicopathological characteristics and poor prognosis in several human cancers. Here, we examined RASSF10 expression in hepatocellular carcinoma (HCC) and its role in hepatocarcinogenesis. RASSF10 mRNA and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fei, Feng, Ying, Li, Peng, Wang, Kun, Feng, Liang, Liu, Yi-Fei, Huang, Hua, Guo, Yi-Bing, Mao, Qin-Sheng, Xue, Wan-Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826205/ https://www.ncbi.nlm.nih.gov/pubmed/26701853 http://dx.doi.org/10.18632/oncotarget.6654

Ejemplares similares

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009)

Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
por: Xue, Wan-Jiang, et al.
Publicado: (2016)

Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma
por: Calvisi, Diego F., et al.
Publicado: (2012)

The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer
por: Richter, A M, et al.
Publicado: (2012)

Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation
por: Li, Wenjiao, et al.
Publicado: (2018)

Epigenetically inactivated RASSF1A as a tumor biomarker
por: Raos, Dora, et al.
Publicado: (2021)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
por: Schagdarsurengin, Undraga, et al.
Publicado: (2010)

RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice
por: Richter, Antje M., et al.
Publicado: (2020)

The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
por: Jiménez, Adriana P., et al.
Publicado: (2017)

RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker
por: Jin, Yongshuai, et al.
Publicado: (2015)

RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours
por: Cooper, WN, et al.
Publicado: (2008)

Predictive value of the serum RASSF10 promoter methylation status in gastric cancer
por: Hu, Yilin, et al.
Publicado: (2019)

RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
por: Amato, Eliana, et al.
Publicado: (2016)

Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2022)

RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer
por: Richter, Antje M., et al.
Publicado: (2019)

Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
por: Richter, Antje M., et al.
Publicado: (2016)

The SARAH Domain of RASSF1A and Its Tumor Suppressor Function
por: Dittfeld, Claudia, et al.
Publicado: (2012)

High Mutability of the Tumor Suppressor Genes RASSF1 and RBSP3 (CTDSPL) in Cancer
por: Kashuba, Vladimir I., et al.
Publicado: (2009)

The cellular functions of RASSF1A and its inactivation in prostate cancer
por: Amin, Karishma S., et al.
Publicado: (2012)

Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK
por: PAN, FENG-PING, et al.
Publicado: (2016)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

SMG1 Acts as a Novel Potential Tumor Suppressor with Epigenetic Inactivation in Acute Myeloid Leukemia
por: Du, Yahui, et al.
Publicado: (2014)

Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer
por: Ma, Junxun, et al.
Publicado: (2017)

Tumor Suppressor RASSF1A Promoter: p53 Binding and Methylation
por: Tian, Yihao, et al.
Publicado: (2011)

RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy
por: García-Gutiérrez, Lucía, et al.
Publicado: (2020)

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells
por: Keller, Maureen, et al.
Publicado: (2019)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

DNA methylation of the p14(ARF), RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients
por: NILSSON, TORBJÖRN K., et al.
Publicado: (2012)

ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
por: Richter, Antje M., et al.
Publicado: (2017)

The Tumor Suppressor Gene, RASSF1A, Is Essential for Protection against Inflammation -Induced Injury
por: Gordon, Marilyn, et al.
Publicado: (2013)

MUC1-C REPRESSES THE RASSF1A TUMOR SUPPRESSOR IN HUMAN CARCINOMA CELLS
por: Rajabi, Hasan, et al.
Publicado: (2019)

Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma
por: Ming, Fei, et al.
Publicado: (2017)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation
por: Zhang, Chaohua, et al.
Publicado: (2023)

Distinct Epigenetic Domains Separated by a CTCF Bound Insulator between the Tandem Genes, BLU and RASSF1A
por: Chang, Jer-Wei, et al.
Publicado: (2010)

Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma
por: Wang, Tao, et al.
Publicado: (2009)

RASSF Family Proteins
por: Clark, Geoffrey J., et al.
Publicado: (2012)

OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
por: Cui, Yan, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_stet8kivqeuf894u5j89bhtjd8